These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37880678)

  • 1. Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis.
    Lavis P; Pingitore J; Doumont G; Garabet A; Van Simaeys G; Lacroix S; Passon N; Van Heymbeek C; De Maeseneire C; Allard J; Collin A; Huaux F; Decaestecker C; Salmon I; Goldman S; Cardozo AK; Bondue B
    Respir Res; 2023 Oct; 24(1):254. PubMed ID: 37880678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Rosenkrans ZT; Massey CF; Bernau K; Ferreira CA; Jeffery JJ; Schulte JJ; Moore M; Valla F; Batterton JM; Drake CR; McMillan AB; Sandbo N; Pirasteh A; Hernandez R
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3705-3716. PubMed ID: 35556159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Ji H; Song X; Lv X; Shao F; Long Y; Song Y; Song W; Qiao P; Gai Y; Jiang D; Lan X
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial results with [
    Mori Y; Kramer V; Novruzov E; Mamlins E; Röhrich M; Fernández R; Amaral H; Soza-Ried C; Monje B; Sabbagh E; Florenzano M; Giesel FL; Undurraga Á
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1605-1611. PubMed ID: 38117298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Detection of Early Pulmonary Fibrosis Disease Using
    Chen J; Luo D; Dai Y; Zhou Y; Pang Y; Wu H; Sun L; Su G; Lin Q; Zhao L; Chen H
    Mol Pharm; 2024 Jul; 21(7):3684-3692. PubMed ID: 38899595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
    Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
    Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Pulmonary Fibrosis and Treatment Efficacy In Vivo with Autotaxin-Specific PET Ligand [
    Deng X; Liu J; Zhou J; Shi Y; Song S; Chen J; Li Y; Yu B; Liang SH; Zhu X
    Mol Pharm; 2024 Oct; 21(10):5171-5181. PubMed ID: 39186477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
    Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
    J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
    Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-CT-assisted identification of the optimal time-window for antifibrotic treatment in a bleomycin mouse model of long-lasting pulmonary fibrosis.
    Buccardi M; Grandi A; Ferrini E; Buseghin D; Villetti G; Civelli M; Sverzellati N; Aliverti A; Pennati F; Stellari FF
    Sci Rep; 2024 Jun; 14(1):14792. PubMed ID: 38926490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
    Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
    BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD
    Guo F; Xu F; Li S; Zhang Y; Lv D; Zheng L; Gan Y; Zhou M; Zhao K; Xu S; Wu B; Deng Z; Fu P
    Eur J Med Res; 2024 Jan; 29(1):68. PubMed ID: 38245795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Tanguy J; Goirand F; Bouchard A; Frenay J; Moreau M; Mothes C; Oudot A; Helbling A; Guillemin M; Bonniaud P; Cochet A; Collin B; Bellaye PS
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3058-3074. PubMed ID: 33580818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis.
    Miura S; Iwamoto H; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38378778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of
    Hiroyama S; Matsunaga K; Ito M; Iimori H; Tajiri M; Nakano Y; Shimosegawa E; Abe K
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4358-4368. PubMed ID: 35876866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis.
    Vizier R; Garnier AR; Dias A; Moreau M; Claron M; Collin B; Denat F; Bellaye PS; Goncalves V
    Mol Pharm; 2023 Jul; 20(7):3613-3622. PubMed ID: 37307296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pulmonary fibrosis induced by paraquat using Al
    Song CY; Liu ZF; Wang P; Su XH; Lu YQ
    Intern Emerg Med; 2023 Sep; 18(6):1673-1679. PubMed ID: 37284931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nitroreductase responsive probe for early diagnosis of pulmonary fibrosis disease.
    Peng S; Liang Y; Zhu H; Wang Y; Li Y; Zhao Z; Li Y; Zhuang R; Huang L; Zhang X; Guo Z
    Redox Biol; 2024 Sep; 75():103294. PubMed ID: 39096854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.